Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Chang

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Clinical Transplantation|July 13, 2022
Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case seriesAmy Chang, Jonathan Mitchell, Jennifer L Alejo, et al.
Transplantation|April 15, 2022
Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An UpdateJonathan Mitchell, Jennifer L Alejo, Teresa P Y Chiang, et al.
Clinical Transplantation|June 7, 2022
Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 dosesAmy Chang, Teresa Py Chiang, Jake D Kim, et al.
JCI Insight|April 27, 2023
Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipientsElizabeth A Thompson, Wabathi Ngecu, Laila Stoddart, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2022
Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipientsAlexandra T Strauss, Amy Chang, Jennifer L Alejo, et al.
Hepatology Communications|July 6, 2022
Letter to the editor: Six-month antibody kinetics and durability in liver transplant recipients after two doses of SARS-CoV-2 mRNA vaccinationAmy Chang, Alexandra T Strauss, Jennifer L Alejo, et al.
Clinical and Translational Radiation Oncology|October 27, 2022
Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineationMonica Lo Russo, Marcel Nachbar, Aisling Barry, et al.
Transplantation|March 15, 2022
Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking BelataceptJonathan Mitchell, Jake Kim, Jennifer L Alejo, et al.
Gynecologic Oncology|July 2, 2023
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203Andre Konski, Snehal Deshmukh, Ann H Klopp, et al.
Gynecologic Oncology|May 21, 2019
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapyKaren M Gil, Stephanie L Pugh, Ann H Klopp, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Clinical Transplantation|July 13, 2022
Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case seriesAmy Chang, Jonathan Mitchell, Jennifer L Alejo, et al.
Transplantation|April 15, 2022
Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An UpdateJonathan Mitchell, Jennifer L Alejo, Teresa P Y Chiang, et al.
Clinical Transplantation|June 7, 2022
Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 dosesAmy Chang, Teresa Py Chiang, Jake D Kim, et al.
JCI Insight|April 27, 2023
Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipientsElizabeth A Thompson, Wabathi Ngecu, Laila Stoddart, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2022
Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipientsAlexandra T Strauss, Amy Chang, Jennifer L Alejo, et al.
Hepatology Communications|July 6, 2022
Letter to the editor: Six-month antibody kinetics and durability in liver transplant recipients after two doses of SARS-CoV-2 mRNA vaccinationAmy Chang, Alexandra T Strauss, Jennifer L Alejo, et al.
Clinical and Translational Radiation Oncology|October 27, 2022
Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineationMonica Lo Russo, Marcel Nachbar, Aisling Barry, et al.
Transplantation|March 15, 2022
Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking BelataceptJonathan Mitchell, Jake Kim, Jennifer L Alejo, et al.
Gynecologic Oncology|July 2, 2023
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203Andre Konski, Snehal Deshmukh, Ann H Klopp, et al.
Gynecologic Oncology|May 21, 2019
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapyKaren M Gil, Stephanie L Pugh, Ann H Klopp, et al.
Pageof 13